A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Recruiting · NCT05303467 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-09-28 | NCT05303467 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Scientific Corporation | 148 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins Interventional Radiology Center | Baltimore | United States | 1 |
| Lenox Hill Hospital | New York | United States | 87 |
| Mayo Jacksonville | Jacksonville | United States | 4 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Northwestern Univerity | Chicago | United States | 1 |
| University of Alabama Birmingham | Birmingham | United States | 20 |
| University of California San Diego | San Diego | United States | 17 |
| University of California San Francisco | San Francisco | United States | 144 |
| Washington University School of Medicine | St Louis | United States | 2 |